Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of SKYCellflu Quadrivalent in Adults and Elderly
NCT02467842Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of NBP607-V in influenza, sponsored by SK Chemicals. Started Oct 2014; status: completed.
02
Drugs
NBP607-V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02467842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467842.